Anhui Provincial Cancer Hospital Aka West Branch of Anhui Province Hospital

Hefei, Anhui 230088

0 studies enrolling now · 4 studies all time

What they study most

Esophageal Squamous Cell Carcinoma (ESCC), Gastric, or Gastroesophageal Junction Adenocarcinoma, Head and Neck Cancer, Head and Neck Squamous Cell Carcinoma, Mantle Cell Lymphoma, Refractory Mantle Cell Lymphoma (MCL), Relapsed Mantle Cell Lymphoma

Studies at this site

• A Study of Tislelizumab in Combination With Investigational Agents in Participants With Head and Neck Squamous Cell Carcinoma — Running, not enrolling
• Study of BGB-11417 Monotherapy in Participants With Relapsed or Refractory Mantle Cell Lymphoma — Running, not enrolling
• A Study of Tislelizumab (BGB-A317) in Combination With Chemotherapy as First Line Treatment in Participants With Advanced Esophageal Squamous Cell Carcinoma — Completed
• Tislelizumab in Combination With Chemotherapy as First-Line Treatment in Adults With Inoperable, Locally Advanced or Metastatic Gastric, or Gastroesophageal Junction Carcinoma — Completed